Invasive Versus Conservative Management of Stable Coronary Artery Disease in CKD
- PMID: 32615149
- PMCID: PMC8981847
- DOI: 10.1053/j.ajkd.2020.06.007
Invasive Versus Conservative Management of Stable Coronary Artery Disease in CKD
Conflict of interest statement
Financial Disclosure: Dr. Sarnak reports membership on the steering committee of trials funded by Akebia, with funds paid to Tufts Medical Center; serving as a consultant for Cardurian, which is developing potential treatments for heart failure; and having attended an advisory board for Bayer within the past 2 years. The remaining authors declare that they have no relevant financial interests.
Comment on
-
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.N Engl J Med. 2020 Apr 23;382(17):1619-1628. doi: 10.1056/NEJMoa1916374. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227754 Free PMC article. Clinical Trial.
References
-
- Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;69(17):2212–2241. doi: 10.1016/j.jacc.2017.02.001 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
